Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Avita Medical announced earnings per share of $-0.19 on revenue of $10.3M. Analysts polled by Investing.com anticipated EPS of $-0.292 on revenue of $8.28M.
Avita Medical shares are down 1.99% from the beginning of the year, still down 37.93% from its 52 week high of $29.34 set on September 18, 2020. They are under-performing the Nasdaq which is up 15.96% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by Novo Nordisk ADR on August 4, who reported EPS of $0.8379 on revenue of $5.26B, compared to forecasts EPS of $0.7823 on revenue of $5.16B.
Eli Lilly had missed expectations on August 3 with second quarter EPS of $1.87 on revenue of $6.74B, compared to forecast for EPS of $1.89 on revenue of $6.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar